Explore advanced lymphoma treatment at Liv Hospital: CAR-T cell therapy, targeted immunotherapy, and precision stem cell transplants. Expert care for global patients.
Send us all your questions or requests, and our expert team will assist you.
Treatment and Procedures
The landscape of lymphoma treatment has been revolutionized in the last decade, transitioning from generalized chemotherapy to high-precision cellular and molecular therapies. At Liv Hospital, we do not view lymphoma as a singular challenge but as a complex biological puzzle. Our treatment philosophy is rooted in “Personalized Oncology,” where every procedure is dictated by the specific genetic markers and molecular subtype of your tumor.
For international patients particularly those from the US seeking advanced alternatives Liv Hospital provides a “Smart Hospital” environment. Here, multidisciplinary experts in hematology, genetics, and nuclear medicine collaborate daily. This integrated approach allows us to offer the world’s most advanced protocols, including CAR-T cell therapy and robotic-enhanced stem cell transplantation, with the efficiency and personalized care that global patients expect.
Every treatment plan at Liv Hospital is designed around three primary clinical objectives. Depending on whether the lymphoma is Hodgkin or Non-Hodgkin, and whether it is indolent or aggressive, our goals include:
At Liv Hospital, we utilize the latest R-CHOP and Pola-R-CHP regimens, which have shown significantly higher success rates in achieving long-term remission for B-cell malignancies.
Traditional chemotherapy attacks all rapidly dividing cells, which often leads to systemic side effects. In contrast, Targeted Therapy focuses on the specific vulnerabilities and proteins inside lymphoma cells. At Liv Hospital, we use these “Smart Drugs” as part of a tailored strategy:
Immunotherapy is one of the most promising frontiers at Liv Hospital. Instead of attacking the cancer directly, these treatments empower your own immune system to do the work.
Cancer cells often “hide” from the immune system by sending inhibitory signals. Drugs like Nivolumab and Pembrolizumab block these signals, effectively “taking the brakes off” your T-cells so they can identify and eliminate the lymphoma.
Liv Hospital is a pioneer in CAR-T Cell Therapy, a groundbreaking procedure for aggressive lymphomas that haven’t responded to other treatments.
As a center of excellence for “Stem Cell” applications, Liv Hospital offers advanced transplant options to restore bone marrow function after intensive treatment.
This is the standard of care for relapsed Hodgkin or Non-Hodgkin lymphoma. We harvest your own healthy stem cells before administering high-dose chemotherapy. Once the chemo has cleared the cancer, your stem cells are re-infused to “reboot” your blood production.
If the patient’s own cells are not viable, we utilize a matched donor (sibling or unrelated). This provides a “Graft versus Lymphoma” effect, where the donor’s immune system continues to fight any remaining cancer cells.
While modern medicine emphasizes biological therapies, traditional methods remain essential tools when used with precision. At Liv Hospital, we utilize:
This “combinatorial approach” ensures that we attack the cancer from multiple angles, increasing the probability of a successful outcome.
Send us all your questions or requests, and our expert team will assist you.
While side effects like fatigue still occur, targeted therapies generally have fewer systemic impacts than traditional chemo. Our supportive care team provides 24/7 management to mitigate nausea and protect your immune health.
For an autologous transplant, patients typically stay in our specialized bone marrow unit for 3–4 weeks. Allogeneic transplants may require 6–8 weeks to ensure successful engraftment and immune stability.
CAR-T is currently indicated for specific aggressive B-cell lymphomas that have not responded to at least two prior lines of therapy. Our hematologists will perform a genetic workup to determine your eligibility.
Patients on oral targeted drugs can usually travel within days. However, for those undergoing intensive chemotherapy or transplants, we recommend staying in Turkey for a few weeks to ensure you are fit for a long-haul flight.
Success rates vary by subtype, but for many common lymphomas, our complete remission rates mirror those of the world’s top oncology centers, often exceeding 80% for early-stage Hodgkin disease.
Your Comparison List (you must select at least 2 packages)
